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Mathematical models can predict solute clearances and
solute concentrations during renal replacement therapy. At
present, however, most nephrologists cannot use these
models because they require mathematical software. In this
report, we describe models of solute transport by convection
and diffusion adapted to run on the commonly available
software program Excels for Macintoshs computers and PCs
running Windowss. Two programs have been created that
can be downloaded from http://www.stanford.edu/
~twmeyer/ or http://dev.satellitehealth.com/research/
journal.asp. The first, called ‘Dr Addis Clearance Calculator’,
calculates clearance values from inputs including the blood
flow Qb, the hematocrit, the ultrafiltration rate Qf, the
dialysate flow rate Qd, the reflection coefficient r and the
mass transfer area coefficient KoA for the solute of interest,
and the free fraction f if the solute is protein bound. Solute
concentration profiles along the length of the artificial kidney
are displayed graphically. The second program, called ‘Dr
Coplon Dialysis Simulator’, calculates plasma solute
concentrations from the clearance values obtained by the
first program and from additional input values including the
number of treatments per week, the duration of the
treatments, and the solute’s production rate and volumes of
distribution. The program calculates the time-averaged
solute concentration and provides a graphic display of the
solute concentration profile through a week-long interval.
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Mathematical models allow us to predict the effect of renal
replacement therapy, so that we may achieve desired solute
clearances while avoiding wasteful excesses in kidney size or
fluid flows.1 Michaels2 first modeled solute diffusion across a
membrane separating countercurrent plasma and dialysate
streams. He was able to express the clearance Cl of a given
solute as a function of the plasma flow rate Qp, the dialysate
flow rate Qd, and KoA, a parameter that describes the
dialyzer’s capacity for diffusive transport of that solute
Cl ¼ Qp 1
1 QpQd
exp KoA
1
Qp
 1Qd
  
 QpQd
0
@
1
A ð1Þ
Villarroel et al.3 and subsequent workers elaborated this
model to describe solute transport by convection as well as
diffusion, so that clearance could be predicted for treatments
combining ultrafiltration and dialysis.4–6 We have recently
adapted the models of Michaels2 and Villarroel et al.3 to
describe the clearance of solutes that are bound to plasma
proteins or other blood constituents.7,8
A major difficulty with the models described above is that
they are not easy to use. Equation (1) represents an analytic
solution to the differential equations which describe diffusive
solute transport at successive points along an artificial kidney.
In other words, it provides a formula that can be used to
calculate clearance from the variables Qb, Qd, and KoA.
However, this formula does not make it easy to visualize what
happens when you change fluid flows or kidney size. Adding
convection to the model has made it even more difficult to
appreciate the effect of changes in the prescription. An
analytic solution has not been obtained for the larger set of
differential equations which describe transport by both
convection and diffusion. Clearance values can be obtained
by solving these equations with mathematical software.
However, without the software and some practice applying
it, the models are of limited use. A practicing nephrologist
cannot employ them to analyze the effect of treatment
changes such as the use of larger kidneys or the addition of
dialysis to CVVH to provide CVVHDF.
Personal computers afford a means to make models of
renal replacement more easily accessible. This was first noted
by Depner,1 who provided BASIC code for urea modeling on
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PCs. Since then, the capacity of standard software programs
has increased dramatically, and users can download modeling
routines without knowing how to enter code. Speed has
increased so that calculations can be accomplished in
seconds, and built-in graphic routines make it easy to display
the solute concentration curves. We took advantage of these
developments to modify recent models of renal replacement
therapy so that the programs could be obtained online and
run on commonly available software.
RESULTS
We first wrote a program that calculates clearance values
from the input variables listed in Table 1. The program
models transport by diffusion and convection across a
membrane between blood and dialysate flowing in opposite
directions, as illustrated in Figure 1. The initial plasma flow
Qp can be calculated from the values for the blood flow Qb
and hematocrit (Hct).
Qp ¼ ð1HctÞQb ð2Þ
If predilution is employed, the plasma flow rate entering the
kidney will be increased, whereas solute concentrations are
proportionally decreased. The model next differentiates
between urea, which diffuses out of red cells as blood flows
through the kidney, and solutes that are removed only from
the plasma. For plasma solutes, solute delivery into the
kidney is the plasma flow rate multiplied by the plasma
concentration, with appropriate corrections for predilution.
For urea, solute delivery includes the estimated urea content
of red cells as described by Depner.1 The model is incomplete
in that it does not allow for partial equilibration of solute
concentrations between red cell water and plasma during
transit through the kidney, which may be the case for
creatinine and other, as yet unidentified, solutes.9
The rate of solute transport varies along the length of the
kidney as solute concentrations in the blood and dialysate
change and as the local ultrafiltration rate changes. This
process can be modeled by dividing the kidney into many
thin layers, as further illustrated in Figure 1. The location of
each layer along the length of the kidney is specified by the
variable x, and the kidney is assigned an arbitrary length of 1,
so that x varies from 0 at the blood inlet to 1 at the blood
outlet. Within each layer, the solute concentrations and
ultrafiltration rate can be considered constant, and the local
solute transport can be calculated from these values. Solute
transport for kidney as a whole can then be determined by
summing solute transport in the individual layers.
If the solute is transported by convection as well as
diffusion, calculation of the local solute transport requires
knowledge of the local ultrafiltration rate. The local
ultrafiltration rate can be determined from the total
ultrafiltration rate Qf, which is specified as part of the
treatment prescription, and from values for the transmem-
brane hydraulic pressure at the two ends of the kidney, as
illustrated in Figure 2. When the local ultrafiltration rate,
denoted Jv,x, is known, the local solute transport Js,x can be
calculated using equations (3)–(6) as developed by Villarroel
et al.3 and further elaborated by Waniewski et al.:6
Js;x ¼ kðCp;x  Cd;xÞ þ Jv;xð1 sÞ Cx ð3Þ
where k is the membrane permeability, Cp,x is the local solute
concentration in the plasma, Cd,x is the local solute
concentration in the dialysate, s is the reflection coefficient
for the solute, and where
Cx ¼ Cp;xð1 fxÞ þ Cd;xfx ð4Þ
with
fx ¼
1
Pex
 1
exp ðPexÞ  1
ð5Þ
Table 1 | Input values required to model clearance
Qb (ml/min) Urea or plasma solute s
Hct (%) Qf (ml/min) f
Qr (ml/min) DP0 (mmHg) Cp (mM)
Qd (ml/min) DP1 (mmHg) Calb (mM)
K0A (ml/min)
Calb, the concentration of the binding protein in the plasma; Cp, the solute
concentration in the plasma; DP0 and DP1, transmembrane hydraulic pressure at the
plasma inlet and plasma outlet ends of the kidney; f, the fraction of the solute which
is free in the plasma; K0A, the kidney’s mass transfer area coefficient for the solute in
question; Qb, arterial blood flow; Qd, dialysate flow; Qf, ultrafiltration rate; Qr,
predilution replacement fluid flow; s, the reflection coefficient for the solute. The
input values for Hct, f, Cp, and Calb are the values measured in blood at the arterial
access.
Qp
Cd,xCp,x
Jv,x
Js,x
Qf
Qd + Qf
QdQp + Qr – Qf
Qr
0
1
x
Figure 1 | Diagram illustrating the approach used to model solute
clearances. Plasma enters (upper left) at a flow of Qp. If predilution is
employed, the plasma is diluted by the replacement fluid flow Qr
before entering the kidney. Dialysate enters (lower right) at a flow
of Qd. Within the kidney, fluid is ultrafiltered from the plasma
compartment to the dialysate compartment at the rate given by Qf.
If the treatment consists only of ultrafiltration, Qd is zero; if the
treatment consists only of dialysis, Qf is zero. The problem is how to
determine the rate at which solute, represented by the stippling, is
transported from the plasma to the dialysate compartment. The
program described here uses the common technique of assigning
the kidney an arbitrary length of one unit and dividing it into a large
number of parallel slices, as illustrated in the figure. The location of
each slice is specified by the variable x, which ranges from 0 at the
blood inlet to 1.0 at the blood outlet. The fluid transport rate Jv,x
in each slice is first determined based on the hydraulic pressure
gradient across the kidney membrane. The local solute transport rate
Js,x is then calculated from Jv,x and from the membrane permeability
k and local solute concentrations in the plasma and dialysate
compartments, Cp,x and Cd,x. Solute transport in the kidney as
a whole is determined by adding the values for Js,x in the individual
slices.
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where Pe´, the Pe´clet number, is a dimensionless quantity that
may be thought of as representing the ratio of convective to
diffusive transport and is given by
Pex ¼ ð1 sÞJv;x
k
ð6Þ
Equation (3) can be thought of as the sum of solute transport
by diffusion alone, represented by the term k(Cp,xCd,x), and
additional solute transport, which occurs when convection is
added, represented by the term Jv;xð1 sÞ Cx. The value Cx in
the latter term is the average solute concentration within the
membrane, which is given by equations (4)–(6). The effect of
the various terms in these equations on the solute
concentration within the membrane can be appreciated by
considering the extremes of purely diffusive transport and
purely convective transport and then considering a combina-
tion of the two processes, as illustrated in Figure 3.
For a protein-bound solute, only the portion that is not
bound will be available for diffusive or convective transport
at the plasma side of the membrane. The value for Cp,x in
equations (3) and (4) must therefore be replaced by the free
concentration Cpf,x with
Cpf ;x ¼ fxCp;x ð7Þ
where f is the fraction of solute that is not bound to protein.
We assume that solute binding is reversible
free soluteþ free albumin
, solute albumin complex
and that it can be described by an association constant KA
such that
KA ¼ Csolutealbumin complex
Cfree soluteCfree albumin
¼ Cp  Cpf
Cpf ðCalb  ðCp  Cpf ÞÞ
ð8Þ
where Calb is the total concentration of albumin, here
assumed to be the binding protein. We further assume that
the time required for the solute to associate with and
dissociate from its binding protein is short in relation to the
time required for plasma to flow through the kidney. This
being the case, the amount of solute removed by the kidney
can exceed the amount of free solute in the plasma entering
the kidney, as illustrated in Figure 4.
a b c
x = 0
x = 1
Qp
Qd Qd
Qp Qp
Qd
Figure 2 | Diagram showing different patterns of ultrafiltration
within the kidney. The horizontal arrows depict the direction and
magnitude of the transmembrane hydraulic pressure DP. The
variation in DP is assumed to be linear from one end of the kidney to
the other, and values for DP at any point can therefore be calculated
from values for DP0 and DP1. The membrane is assumed to have
uniform hydraulic permeability, so that the fluid transport is
proportional to the transmembrane hydraulic pressure. In each of the
cases illustrated, the average transmembrane hydraulic pressure is
the same, so that Qf, which is the sum of fluid transport along the
length of the kidney, is also the same. In (a), the transmembrane
pressure is uniform. Our program assumes a uniform transmembrane
pressure if specific values for DP0 and DP1 are not entered. (b) The
more realistic assumption that DP is greater at the blood inlet than at
the blood outlet. Convective transport is therefore most prominent
near the blood inlet and the clearance of small free solutes is very
slightly higher than with uniform DP. In (c), the change in DP along
the kidney has increased to the point where DP1 is negative, so that
there is ‘back filtration’ of dialysate toward the blood outlet. Back
filtration occurs with some current kidneys and may be enhanced by
future kidney designs.16 These designs increase convective solute
transport by increasing the ultrafiltration rate toward the blood inlet
end of the kidney far above the desired net fluid removal rate. Back
filtration of dialysate toward the blood outlet end provides
replacement fluid. In general, imposition of this fluid flow pattern has
little effect on the clearance of small molecules, but may significantly
increase the clearance of larger solutes that are transported most
effectively by convection.
a b cCp Cp CpCd
CdCd
Figure 3 | Solute concentrations within the membrane of
the artificial kidney as predicted by Villarroel et al.3 for
solutes with reflection coefficient r¼ 0. The membrane is
represented by the gray shaded bars. The diffusivity of the
membrane, which is its solute permeability per unit thickness, is
assumed to be uniform. In pure dialysis (a, transport by diffusion
without convection), the solute concentration falls linearly from
Cp in the plasma compartment to Cd in the dialysate compartment.
In pure ultrafiltration (b, transport by convection without
diffusion), the solute concentration is constant throughout the
membrane and Cd¼ Cp. When convection is combined with
diffusion, the solute concentration profile is intermediate and
varies with Pe´, the Pe´clet number. (c) The solute concentration
profile for Pe´¼ 4. The curve is ‘convex up’ as fluid is being
ultrafiltered from plasma to dialysate and convective transport
is in the same direction as diffusive transport. The curve will be
‘convex down’ where there is back filtration of dialysate into the
plasma compartment.
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Equations (7) and (8) can be rearranged to provide a local
value for the solute free fraction (equation (9) below).
fx ¼ Cpf ;x
Cp;x
¼ KACp;x  KACalb;x  1
2KACp;x
þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
K2AC
2
alb;x  2K2ACalb;xCp;x þ K2AC2p;x þ 2KACalb;x þ 2KACp;x þ 1
q
2KACp;x
ð9Þ
This equation reveals that the free fraction will change as the
concentrations of the solute and its binding protein change.
For instance, predilution will lower the total solute
concentration and the binding protein concentration, so that
f will be higher at the plasma inlet of the kidney than in a
sample of the patient’s plasma. As plasma flows through the
kidney, f may change further as the binding protein is
concentrated by plasma ultrafiltration and as solute is
removed. Over the course of a treatment session, f may tend
to fall as the plasma solute concentration falls. The clearance
rate for a protein-bound solute is thus concentration
dependent, unlike the clearance rates for urea and other
unbound solutes. However, in general, f will change very little
if the concentration of a protein-bound solute is much less
than the concentration of its binding protein. More
complicated results are predicted if the solute concentration
approaches or exceeds the binding protein concentration, but
it is uncertain whether this occurs in clinical practice. In our
model, values for Cp, Calb, and f in the patient’s plasma are
entered. The model then obtains a value for KA from
equations (7) and (8) and uses equation (9) to calculate local
values for f as plasma flows through the kidney.
Equation (3), with appropriate substitution of Cpf for
Cp using values for f supplied by equation (9) and values
for Jv obtained as shown in Figure 2, describes solute
transport at each point along the kidney. The usual way to
obtain total solute transport is to express equation (3) as a
differential
Js;x dx ¼ ðkðCp;x  Cd;xÞ
þ Jv;xð1 sÞ CxÞdx
ð10Þ
Values for Js,x, Jv,x, and k are expressed per unit of dialyzer
length. The membrane permeability k is assumed to be
constant along the length of the kidney, and as the kidney has
an assigned length of one unit, the value for k expressed in
ml/min/unit length is the same as the value for the mass
transfer area coefficient KoA expressed in ml/min. Two
additional equations impose the conservation of volume and
the conservation of mass. The equation:
Jv;x dx ¼ dQp;x ¼ dQd;x ð11Þ
specifies that fluid flow across the membrane decreases the
plasma flow rate and increases the dialysate flow rate. The
equation
Js;xdx ¼ dðQp;xCp;xÞ
¼ dðQd;xCd;xÞ
ð12Þ
specifies that the amount of solute leaving the plasma is equal
to the amount of solute appearing in the dialysate.
Mathematical software can then be used to solve equations
(10)–(12). A value for total solute transport is obtained based
on the input variables listed in Table 1 and solute clearance is
calculated using the standard formula
Cl ¼ total solute transport
plasma solute concentration
ð13Þ
To obtain modeled clearance values using routinely available
software, we adopted a slightly different procedure. The
length of the kidney was divided into 1000 finite slices instead
of an infinite number of differential slices. Our program then
calculates solute transport in each slice, beginning at the
blood inlet. For the first slice, all of the values necessary to
calculate solute transport are available from the input values
except for Cd,0, the solute concentration in the dialysate
leaving the kidney. To calculate the solute flux in the first slice
using equation (3), the program picks an arbitrary, and
invariably erroneous, value for Qd,0. The calculated solute
transport in the first slice is then used to obtain values for Cp
and Cd in the second slice, solute transport in the second slice
is calculated using these values, and the process is repeated
until the last slice is reached. At this point, the program has
calculated a value for Cd,1, the solute concentration in the
dialysate entering the kidney. This calculated value will not
Figure 4 | The diffusion of a protein-bound solute through the
membrane of the artificial kidney. Most of the solute ( ) in the
plasma is bound to protein ( ). Only the free portion of the solute is
available for diffusion, and diffusive transport (straight arrow) will
therefore occur only if the solute concentration in the dialysate is
kept low. As solute diffuses into the dialysate, dissociation of solute
from the binding protein (curved arrow) maintains the equilibrium
between free and bound solute in the plasma compartment. As
solute dissociates from its binding protein as plasma flows through
the kidney, the clearance of even a tightly bound solute will
approach the theoretical maximum imposed by the plasma flow
rate if KoA is large enough and Qd is increased enough to keep
the dialysate solute concentration near zero.7
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equal zero, the true solute concentration in dialysate entering
the kidney, unless by extraordinary coincidence the arbitrary
value selected for Cd,0 was correct. This problem is addressed
by picking a different value for Cd,0 and recalculating solute
transport in all the slices. The program repeats this process
using varying values for Cd,0 until the calculated value for
Cd,1 becomes arbitrarily close to the true value of zero. The
chosen value for Cd,0 is then deemed correct and the program
sums the last series of calculated values for transport in each
slice to obtain values for total solute transport. This method
is computationally inefficient, but the speed of modern
desktop computers is such that the entire series of
calculations can be performed in seconds. Results obtained
with the program are illustrated in Figure 5. The division of
the length of the kidney into 1000 slices was arbitrary. We
presume that the accuracy of the calculations increases with
the number of slices, but have not proved this mathemati-
cally. In testing the program, however, we found that
increasing the number of slices from 1000 to 10 000 made a
difference of less than 1% in the clearance values calculated
for a wide range of prescriptions.
For the special case of treatment by ultrafiltration only,
where Qd is zero, the program calculates total solute flux by
the simpler equation
Js ¼ Jvð1 sÞCpf ð14Þ
where the total fluid flux Jv is equal to Qf, the ultrafiltration
rate, and where Cpf, the free solute concentration, is
appropriately corrected for the effect of predilution.
Values obtained using the program described above are
instantaneous clearances. That is, the program calculates the
rate in ml/min of plasma at which a solute will be cleared
while the renal replacement system is operating according to
a given prescription. A second program uses these clearance
values to predict plasma solute levels over a week-long period
of renal replacement therapy. This program requires input
variables in addition to those used to calculate clearance, as
summarized in Table 2. The first necessity is to specify the
duration and frequency of treatment. For the sake of
simplicity, the program described here does not allow
treatment more than once a day and assumes that each
treatment starts at the same time of day. Hemofiltration
treatment is modeled by setting Qd equal to zero and
continuous renal replacement therapy is modeled by setting
treatment time to 24 h.
The next requirement is to specify the endogenous
clearance, which may reflect residual renal clearance,
extrarenal clearance, or a combination of the two. The
endogenous clearance is assumed to be constant, so that the
clearance during treatments is the sum of the endogenous
clearance and the renal replacement clearance. Finally,
calculation of plasma solute concentration profiles requires
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Figure 5 | Screenshot of the clearance calculator program. The input variables, entered on the left, are those summarized in Table 1. In this
example, the solute is urea, Qb is 350 ml/min, Qd and KoA are 700 ml/min, and K, the clearance, is 277 ml/min.
Table 2 | Input values required to model the plasma solute
concentration profile
Duration (h) One or two compartments
Treatment days Volume of first compartment (l)
Clendogenous (ml/min) Volume of second compartment (l)
Generation rate (mg/day) KC (ml/min)
Clendogenous, endogenous clearance; KC, the intercompartmental mass transfer area
coefficient (if two compartments are specified).
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that we specify the rate of solute production and the
volume(s) in which the solute is distributed. Our program
allows users to specify whether a solute is distributed in one
or two compartments as illustrated in Figure 6. When two
compartments are chosen, the program assumes that solute
transport between the two compartments Js,1) 2 can be
described by the equation:
Js;1)2 ¼ KCðC1  C2Þ ð15Þ
where KC is an intercompartmental mass transfer area
coefficient and where C1 and C2 are the solute concentrations
in the first and second compartments, respectively. The
program allows users either to enter individual values for KC
and the compartment volumes or to employ a standard two
compartment model for urea distribution as described by
Depner.1 If the standard model is employed, only the volume
of total body water TBW at the end of treatment must be
specified. The program then divides body water into a first
compartment containing one-third the total volume, corre-
sponding to the extracellular fluid, and a second compart-
ment containing two-thirds the total volume, corresponding
to the intracellular fluid. The value for KC is calculated as
KC ¼ 800 TBW
42
	 
2=3
ð16Þ
This formula sets KC for urea at 800 ml/min in a person with
TBW 42 l and adjusts KC in proportion to changes in cell
surface area, which are presumed to accompany changes in
body size.
The program further assumes that the patient is in a
steady state. The patient is assigned a constant rate of fluid
intake and the program sets the ultrafiltration rate during
treatment to remove this fluid so that volumes remain
constant at the beginning of each week. If the two-
compartment model for urea is selected, the program
assumes that volume changes are restricted to the first
compartment, corresponding to the extracellular fluid. This
assumption is not strictly correct, but produces reasonably
accurate urea concentration profiles.1 Other solutes may
require different treatment. For instance, in the case of very
large solutes, the first and second compartments may
correspond to the plasma and interstitial fluid.10 In this
case, the assumption that volume changes are restricted to
the first compartment would cause large errors. When
individual volumes for two compartments are assigned, the
program therefore allows the user to divide the volume
removed and replaced between the two compartments in a
fixed proportion.
To obtain steady-state plasma concentration profiles, the
program uses an iterative process similar to that used to
obtain clearance values. The week is divided into 1680 slices
and calculations are repeated while varying that assumed
value for the solute concentration at the beginning of the
week until the calculated solute concentration at the end of
the week is arbitrarily close to the beginning value. Results
obtained are illustrated in Figure 7. Numeric results include
the clearance provided by renal replacement, which is the
same value as calculated by our clearance program, and the
time-averaged solute concentration, or TAC. The program
also calculates the average peak concentration, or APC, as this
could be a more important determinant of toxicity than the
TAC for some solutes.11 A hold feature allows the
concentration profiles achieved with different prescriptions
to be superimposed, making them easier to compare. The
division of the week into 1680 10-min slices is again
arbitrary. However, we found that increasing the number of
slices sixfold made a difference of less than 2% in calculated
values for TAC and APC for a wide variety of test cases.
Differences up to 4% in values for TAC and APC were
obtained only for cases in which clearance was restricted by
making KoA very low. For the special case of urea, we found
further that the program provided results close to those
obtained with the Ureakin program described by Depner.1
DISCUSSION
The authors believe that these programs can help users
evaluate the effect of proposed changes in the renal
replacement prescription. For example, users can model the
effect of kidneys with large KoA values, which are now being
heavily advertised. Users can also compare the effect of
changes in the duration and frequency of treatment, and
predict solute levels that will be achieved by daily treatment.
Finally, the program can be used to compare the clearance of
urea and solutes whose removal is restricted by protein
binding or large size. The authors have been particularly
interested in the model’s prediction that increasing KoA and
Qd above commonly used values will have little effect on urea
Q f
JsJs
Fluid
intake
V2 C2
V1 C1
KC
Endogenous
function
Renal replacement
therapy
Solute
production
Figure 6 | Diagram showing how solute distribution between two
body compartments is modeled. Solute is produced at a constant
rate and added to a first compartment with volume V1. Passive solute
transport between this compartment and a second compartment
with volume V2 is governed by the mass transfer area coefficient KC
for the intercompartmental membrane and by the solute concen-
trations C1 and C2. Solute is removed from the first compartment,
which must include the plasma, by renal replacement treatment and
by endogenous clearance. Endogenous clearance, which represents
the sum of residual renal clearance and extrarenal clearance, is
assumed to be constant, whereas renal replacement may be
intermittent. In the model illustrated here, V2 is kept constant and
fluid removed by renal replacement therapy is replaced by fluid
intake into the first compartment.
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concentrations, but greatly reduce the levels of protein-
bound solutes.7
Limitations of the programs should be acknowledged. The
most important of these derive from our limited knowledge
of uremic toxins. Even for urea, which is the most extensively
studied solute removed by renal replacement therapy,
estimates of distribution volumes and generation rates may
be imprecise.12 Information about other solutes is much less
complete.13 For most solutes, generation rates and volumes
of distribution are not known. Information on the extent of
protein binding is also limited, and the possibility that
uremic solutes bind to other blood components such as lipids
or cell membranes has received little attention. Values for KoA
and s, which together describe the interaction of solutes with
the artificial kidney, are often not available. Kidney
manufacturers provide in vitro clearance values for urea
(mw 60), creatinine (mw 113), and vitamin B12 (mw 1355).
In vitro KoA values, which may have to be adjusted downward
for in vivo use, can be calculated from these clearance values
using a modified form of (equation (1))2,14
K0A ¼ QpQd
Qp  Qd ln
1 Cl=Qp
1 Cl=Qd
	 

ð17Þ
KoA values for other solutes can be estimated based on their
size, but factors other than size determine solute diffusivity
through a given membrane material and thus affect KoA.
Values for the reflection coefficient s, which determine the
rate of convective transport for large solutes, have been
reported in only a few cases. Despite these limitations, we feel
that the ability to predict clearance values and solute
concentration profiles can be useful. Hopefully, modeling
will become increasingly valuable as information about
uremic solutes accumulates.
The models described here can be downloaded as Excels
workbooks from http://www.stanford.edu/~twmeyer/ or
http://dev.satellitehealth.com/research/journal.asp. Dr Addis
Clearance Calculator is named for Thomas Addis whose ‘urea
ratio’ provided the first useful measure of kidney function
and was a precursor to the concept of clearance.15 Dr Coplon
Dialysis Simulator is named for Norman Coplon who
founded the non-profit dialysis provider Satellite Healthcare
and Satellite Research. These programs have not been
clinically tested or approved by the Food and Drug
Administration. We therefore offer them as teaching tools
rather than guides to the prescription of dialysis in patients.
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